Table 3.
PSG Variable (mean ± SD) |
Screening Night (n=39) |
3-Weeks of Therapeutic CPAP (n=39) |
p value* |
---|---|---|---|
% Stage 1 Sleep | 23.5 ± 14.5 | 16.3 ± 10.1 | 0.001 |
% Stage 2 Sleep | 59.6 ± 13.8 | 64.2 ± 11.5 | 0.06 |
% Stage 3 Sleep | 1.9 ± 3.1 | 4.0 ± 6.2 | 0.006 |
% Stage 4 Sleep | 0.1 ± 0.2 | 0.2 ± 0.7 | 0.26 |
% REM Sleep | 15.0 ± 8.7 | 15.3 ± 6.6 | 0.95 |
TST (min) | 372.0 ± 87.1 | 343.6 ± 72.5 | 0.05 |
WASO (min) | 126.0 ± 79.5 | 92.3 ± 44.6 | 0.005 |
TIB (min) | 507.2 ± 77.0 | 458.0 ± 68.6 | 0.002 |
SP (min) | 498.0 ± 78.0 | 435.9 ± 77.2 | <0.001 |
SO (min) | 9.2 ± 17.2 | 19.9 ± 32.2 | 0.06 |
SE (%) | 75.1 ± 14.5 | 78.8 ± 10.0 | 0.11 |
ArI | 8.4 ± 5.1 | 4.7 ± 2.7 | 0.005 |
p-value from paired analysis is shown.